Stroke rates are low among COVID-19 patients—but when they occur, the risk of death is substantial

Michael Walter | | Cardiovascular Business | COVID-19
Hypertension patients measured their blood pressure less frequently during the early months of the COVID-19 pandemic, according to new research published in Hypertension. In addition, when those patients did measure their blood pressure, the readings were less healthy than they had been before the pandemic.

The stroke rate among COVID-19 patients is low, according to new research published in Stroke. Cryptogenic stroke is more common than normal, however, and in-hospital mortality is significantly higher.

“Given early reports of an association between COVID-19 and cerebrovascular disease, there is a critical, unmet need to define associations and outcomes of patients with cerebrovascular disease and COVID-19,” wrote lead author Shadi Yaghi, MD, department of neurology at New York University School of Medicine, and colleagues. “Understanding factors associated with stroke in patients with COVID-19 will aid in the diagnosis, treatment, and prevention of COVID-19 associated cerebrovascular disease as well as potentially identify underlying mechanisms.”

The study’s authors tracked more than 3,500 hospitalized COVID-19 patients who received treatment from the same health system in New York City from March 15 to April 19, 2020. While just 0.9% of patients had imaging-confirmed ischemic stroke, some of the other findings were more troublesome.

For instance, cryptogenic stroke was much higher among COVID-19 patients (65.6%) than historical controls (30.4%). For in-hospital mortality, the increase was even more significant (63.6% vs. 9.3%).

Patients with confirmed COVID-19 also had more severe strokes, with a median score of 19 on the National Institutes of Health Stroke Scale; non-COVID-19 patients had a median score of 8. D-dimer levels were also considerably higher—the median highest level was more than 10,000 for COVID-19 patients and 525 for non-COVID-19 patients.

“In patients with COVID-19 and ischemic stroke, a majority of strokes were classified as cryptogenic, possibly related to an acquired hypercoagulability, and were associated with increased mortality,” Yaghi et al. wrote. “Ongoing studies are testing the utility of therapeutic anticoagulation for stroke and other thrombotic event prevention, in select patients with COVID-19 and laboratory evidence suggestive of hypercoagulability.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

AHA issues a scientific statement on COVID-19 cardiac arrhythmias
History of COVID-19 doubles long-term risk of heart attack, stroke or death
Monitoring acute heart patients at home linked to considerable cost savings
A key update on how COVID-19 caused dangerous MIS-C inflammation in children
Q&A: Cardiologist Karen Joynt Maddox on why new healthcare policies are not improving outcomes
COVID-19 vaccines helped heart failure patients stay out of the hospital and live longer

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."